Navigation Links
Festschrift Issue Honoring Judah Folkman, M.D. in Lymphatic Research and Biology

NEW ROCHELLE, N.Y., Jan. 6 /PRNewswire/ -- Dedicated to the memory and scientific accomplishments of Dr. Judah Folkman, who pioneered the fields of angiogenesis and vasculogenesis and shed light on the link between blood supply and neoplastic disease, the newly released special double issue (Volume 6, Number 3-4) of Lymphatic Research and Biology includes a series of papers that reflect the research impact of one of the pre-eminent physician-scientists of his generation. Lymphatic Research and Biology is a peer-reviewed journal published by Mary Ann Liebert, Inc. ( The issue is available free online at

"Not only did Judah Folkman single-handedly create the research discipline of angiogenesis, he also played a very fundamental role in the extension of the same principles to the field of lymphangiogenesis research," says Stanley G. Rockson, MD, Editor-in-Chief of the Journal and Chair of the Scientific Advisory Board of the Lymphatic Research Foundation. Dr. Rockson, who is the Chief of Consultative Cardiology, the Allan and Tina Neill Professor of Lymphatic Research and Medicine, and Director of the Stanford Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, feels that "his impact as a teacher and mentor is almost incalculable, and we are proud to present these contributions by leading scientists whose training and career path directly reflect the impact of Dr. Folkman's work and teaching."

Leah Cueni and Michael Detmar provide an in-depth review of the field in "The Lymphatic System in Health and Disease," and Carrie Shawber and Jan Kitajewski describe "Arterial Regulators Taken Up by Lymphatics." In the paper "Why and How Do Tumors Stimulate Lymphangiogenesis?," Yihai Cao explains the processes behind increased lymphatic supply to cancerous lesions. Dean Felsher explores the phenomena of oncogene addiction, cellular senescence, and the angiogenic switch in a report entitled, "Reversing Cancer From Inside and Out." In a forward-looking review, Steven Stacker and Marc Achen present "From Anti-Angiogenesis to Anti-Lymphangiogenesis: Emerging Trends in Cancer Therapy." A report by Michael Mancuso, Frank Kuhnert, and Calvin Kuo focuses on "Developmental Angiogenesis of the Central Nervous System."

Lymphatic Research and Biology is an authoritative peer-reviewed journal published quarterly in print and online. As the official journal of the Lymphatic Research Foundation, it provides an interdisciplinary forum for the world's leading biomedical investigators to discuss current and anticipated developments in lymphatic biology and pathology. Original research derives from a variety of investigative disciplines, including genetics, biochemistry and biophysics, cellular and molecular biology, physiology and pharmacology, anatomy, developmental biology, and pathology. A complete table of contents and free sample issue may be viewed online at

Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, books, and newsmagazines is available at

    Mary Ann Liebert, Inc.
    140 Huguenot St., New Rochelle, NY 10801-5215
    Phone: (914) 740-2100    
    (800) M-LIEBERT
    Fax:  (914) 740-2101

Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext. 2156,

SOURCE Mary Ann Liebert, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. New Edition of Definitive Resource in Tissue Engineering Released Today
3. BioMS Medical announces its intention to renew a normal course issuer bid
4. Pressure BioSciences, Inc. Issued First Patent in Canada
5. Boydens Summit Practice Featured in the September Issue of New Jersey Business Magazine
6. Pharmos Issues Letter to Shareholders
7. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
8. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
9. HHS Issues First Department-Wide Report on Personalized Health Care
10. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
11. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
Post Your Comments:
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving ... marijuana products targeting the needs of consumers who are incorporating medical marijuana into ... in Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving ...
(Date:10/6/2017)... , ... October 06, 2017 , ... ... within the healthcare and technology sector at their fourth annual Conference where founders, ... 30 inspiring speakers and the ELEVATE pitch competition showcasing early stage digital health ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):